Method | Penicillin | Ciprofloxacin | Spectinomycin | Ceftriaxone | Tetracycline | Tetracycline | |||||||||||
S | LS | R | S | LS | R | S | LS | R | S | LS | R | S | LS | R | TRNG | N-TRNG | |
Etest | 34 (11.5) | 156 (52.9) | 105 (35.6) | 1 (0.3) | 48 (16.3) | 246 (83.4) | 295 (100) | – | 0 | 283 (95.9) | 12 (4.1) | 0 | 116 (39.3) | 91 (30.8) | 30 (10.2) | 58 (19.7) | 237 (80.3) |
CDS | 30 (10.2) | 151 (51.2) | 114 (38.6) | 1 (0.3) | 27 (9.2) | 267 (90.5) | 295 (100) | – | 0 | 282 (95.6) | 13 (4.4) | 0 | – | – | – | 60 (20.3) | 235 (79.7) |
CLSI | 21 (7.1) | 157 (53.2) | 117 (39.7) | 1 (0.3) | 64 (21.7) | 230 (78.0) | 295 (100) | 0 | 0 | 283 (95.9) | 12 (4.1) | 0 | 80 (27.1) | 103 (35.9) | 64 (21.7) | 48 (16.3) | 247 (83.7) |
CLSI, Clinical and Laboratory Standards Institute; LS, less susceptible; N-TRNG, not-TRNG; R, resistant; S, susceptible; TRNG, tetracycline-resistant N. gonorrhoeae.